Effect of transjugular intrahepatic portosystemic shunt on pulmonary gas exchange in patients with portal hypertension and hepatopulmonary syndrome

World Journal of Gastroenterology

Volumn 11, Issue 43, 2005, Pages 6858-6862

  Martínez Pallí, Graciela ^a   Drake, Britt B ^b   García Pagán, Joan Carles ^a   Barberà, Joan Albert ^a   Arguedas, Miguel R ^b   Rodriquez Roisin, Robert ^a   Bosch, Jaume ^a   Fallon, Michael B ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Hepatopulmonary syndrome; Portal hypertension; Pulmonary gas exchange; Transjugular intrahepatic portosystemic shunt

Indexed keywords

CARBON DIOXIDE; OXYGEN;

ADULT; AGED; ARTERIAL GAS; ARTERIAL OXYGEN SATURATION; ARTICLE; CARBON DIOXIDE TENSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HEMODYNAMICS; HEPATOPULMONARY SYNDROME; HUMAN; LUNG FUNCTION TEST; LUNG GAS EXCHANGE; MALE; OXYGEN TENSION; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; SAFETY; SPAIN; TOTAL LUNG CAPACITY; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 30744475704     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i43.6858     Document Type: Article

References (28)

1. Casado M, Bosch J, Garcia-Pagan JC, Bru C, Banares R, Bandi JC, Escorsell A, Rodriguez-Laiz JM, Gilabert R, Feu F, Schorlemer C, Echenagusia A, Rodes J. Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology 1998; 114: 1296-1303
2. Riegler JL, Lang KA, Johnson SP, Westerman JH. Transjugular intrahepatic portosystemic shunt improves oxygenation in hepatopulmonary syndrome. Gastroenterology 1995; 109: 978-983
3. Lasch HM, Fried MW, Zacks SL, Odell P, Johnson MW, Gerber DA, Sandhu FS, Fair JH, Shrestha R. Use of transjugular intrahepatic portosystemic shunt as a bridge to liver transplantation in a patient with severe hepatopulmonary syndrome. Liver Transpl 2001; 7: 147-149
4. Selim KM, Akriviadis EA, Zuckerman E, Chen D, Reynolds TB. Transjugular intrahepatic portosystemic shunt: a successful treatment for hepatopulmonary syndrome. Am J Gastroenterol 1998; 93: 455-458
5. Allgaier HP, Haag K, Ochs A, Hausentein KH, Jeserich M, Krause T, Heilmann C, Gerok W, Rossle M. Hepatopulmonary syndrome: succesful treatment by transjugular intrahepatic portosystemic shunt (TIPS) (letter). J Hepatoly 1995; 23: 102-105
6. Corley DA, Scharschmidt B, Bass N, Somberg K, Gold W. Lack of efficacy of TIPS for hepatopulmonary syndrome Gastroenterology 1997; 113: 728-730
7. Paramesh AS, Husain SZ, Shneider B, Guller J, Tokat I, Gondolesi GE, Moyer S, Emre S. Improvement of hepatopulmonary syndrome after transjugular portosystemic shunting: case report and review of literature. Pediatric transplant 2003; 7: 157-162
8. Rodriguez-Roisin R, Krowka MJ, Herve P, Fallon MB. Pulmonary-Hepatic vascular Disorders (PHD). Eur Respir J 2004; 24: 861-880
9. Fallon MB, Abrams GA. Pulmonary dysfunction in chronic liver disease. Hepatology 2000; 32: 859-865
10. Martínez GP, Barbera JA, Visa J, Rimola A, Pare JC, Roca J, Navasa M, Rodes J, Rodriguez-Roisin R. Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatol 2001; 34: 651-657
11. Arguedas MR, Abrams GA, Krowka MJ, Fallon MB. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 2003; 37: 192-197
12. Krowka MJ, Porayko MK, Plevak DJ, Pappas C, Steers JL, Krom RAF, Wiesner RH. Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review. Mayo Clin Proc 1997; 72: 44-53
13. Babbs C, Warners TW, Haboubi NY. Non cirrhotic portal hypertension with hypoxemia. Gut 1988; 29: 129-131.
14. De BK, Sen S, Biswas PK, Mandal SK, Das D, Das U, Guru S, Bandyopadhyay K. Occurrence of hepatopulmonary syndrome in Budd-Chiari syndrome and the role of venous decompression. Gastroenterology 2002; 122: 897-903
15. Abrams GA, Fallon MB. The hepatopulmonary syndrome. Clin Liver Dis 1997; 1: 185-200
16. Azoulay D, Castaing D, Dennison A, Martino W, Eyraud D, Bismuth H. Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study. Hepatology 1994; 19: 129-132
17. Rodriguez-Laiz JM, Banares R, Echenagusia A, Casado M, Camunez F, Perez-Roldan F, de Diego A, Cos E, Clemente G. Effects of transjugular intrahepatic portasystemic shunt (TIPS) on splanchnic and systemic hemodynamics, and hepatic function in patients with portal hypertension. Preliminary results. Dig Dis Sci 1995; 40: 2121-2127
18. Van Der Linden P, Le Moine O, Ghysels M, Ortinez M, Deviere J. Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: effects on right ventricular function. Hepatology 1996; 23: 982-987
19. Francois E, Garcia-Pagan JC, Bru C, Feu F, Gilabert R, Escorsell A, Bosch J, Rodes J. Effects of percutaneous intrahepatic portosystemic shunt on splanchnic and systemic hemodynamics in patients with portal hypertension. Gastroenterol Hepatol 1997; 20: 11-14
20. Martinez-Pallí G, Barbera JA, Navasa M, Roca J, Visa J, Rodriguez-Roisin R. Hepatopulmonary syndrome associated with cardiorespiratory disease. J Hepatol 1999; 30: 882-889
21. Krowka MJ. Caveats concerning hepatopulmonary syndrome. J Hepatol 2001; 34: 756-758
22. Roca J, Wagner PD. Contribution of multiple inert gas elimination technique to pulmonary medicine. 1. Principles and information content of the multiple inert gas elimination technique. Thorax 1994; 49: 815-824
23. Bosch J, García-Pagán JC. Complications of cirrhosis. I. Portal hypertension. J Hepatol 2000; 32S: 141-156
24. Cremona G, Higenbottam TW, Mayoral V, Alexander G, Demoncheaux E, Borland C, Roe P, Jones GJ. Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome. Eur Respir J 1995; 8: 1883-1885
25. Lotterer E, Wengert A, Fleig WE. Transjugular intrahepatic portosystemic shunt: short term and lshort-term effects on hepatic and systemic hemodynamics in patients with cirrhosis. Hepatology 1999; 29: 632-639
26. Bernadich C, Bandi JC, Melin P, Bosch J. Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension. Hepatology 1997; 26: 262-267
27. Jalan R, Damink SO, Deutz N, Redhead D, Lee A. Increased cerebral and peripheral vasodilation, and whole body nitric oxide (NO) production after insertion of a transjugular intrahepatic portosystemic stent-shunt (TIPSS) in patient with cirrhosis. J Hepatol 2002; 36: A178:55
28. Colombato LA, Spahr L, Martinet JP, Dufresne MP, Lafortune M, Fenyves D, Pomier-Layrargues G. Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients. Gut 1996; 39: 600-604